Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The new pemphigus variants.

N D Robinson1, T Hashimoto, M Amagai

  • 1Department of Dermatology, Northwestern University Medical School, Chicago, Illinois, USA.

Journal of the American Academy of Dermatology
|May 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement of redness and hyperkeratosis in a case of Nagashima-type palmoplantar keratosis during Tofacitinib treatment for ulcerative colitis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Analysis of clinical characteristics, prognosis and antibody pathogenicity of pemphigus patients positive for anti-desmoglein IgG autoantibodies in remission: a retrospective cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Cholesterol 25-hydroxylase is a metabolic switch to constrain T cell-mediated inflammation in the skin.

Science immunology·2021
Same author

Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Urticaria due to natto (fermented soybeans).

Clinical and experimental dermatology·2021
Same author

Linear and disseminated porokeratosis in one family showing identical and independent second hits in MVD among skin lesions, respectively: a proof-of-concept study.

The British journal of dermatology·2021
Same journal

Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

Journal of the American Academy of Dermatology·2026
Same journal

Safety of Biologic Therapy in Psoriasis Patients With Malignancy.

Journal of the American Academy of Dermatology·2026
Same journal

Letter from the Editor: Glucagon-Like Peptide-1 (GLP-1) agonists in dermatology.

Journal of the American Academy of Dermatology·2026
Same journal

Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

Journal of the American Academy of Dermatology·2026
Same journal

Parallel-Polarized Dermoscopy for Acral Parallel Pattern Analysis.

Journal of the American Academy of Dermatology·2026
See all related articles

This review covers rare autoimmune blistering diseases, including pemphigus herpetiformis, IgA pemphigus, and paraneoplastic pemphigus. It details their specific target antigens, pathogenesis, and treatments.

Area of Science:

  • Dermatology
  • Immunology
  • Autoimmune Diseases

Background:

  • Pemphigus encompasses autoimmune disorders causing skin and mucous membrane blisters.
  • Histology reveals acantholysis, with autoantibodies targeting epidermal cell surface components.
  • Rare variants like pemphigus herpetiformis, IgA pemphigus, and paraneoplastic pemphigus have emerged since the 1970s.

Purpose of the Study:

  • To review recent laboratory findings on rare and atypical pemphigus variants.
  • To elucidate specific target antigens in these pemphigus subtypes.
  • To provide a comprehensive overview of their clinical and immunopathological aspects.

Main Methods:

  • Literature review of recent laboratory investigations.
  • Analysis of clinical presentations and histologic findings.

Related Experiment Videos

  • Examination of immunopathology and target antigens.

    • Main Results:

    • Significant data have been gathered on rare pemphigus variants.
    • Specific target antigens for these variants have been identified.
    • Understanding of pathogenesis, treatment, and clinical course has advanced.

    Conclusions:

    • Atypical pemphigus variants present unique clinical and immunopathological features.
    • Identification of specific target antigens is crucial for understanding pathogenesis.
    • Further research is needed to optimize treatment and management strategies for these rare diseases.